These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2260923)

  • 1. Expression of the structural proteins of dengue 2 virus and yellow fever virus by recombinant vaccinia viruses.
    Hahn YS; Lenches EM; Galler R; Rice CM; Dalrymple J; Strauss JH
    Arch Virol; 1990; 115(3-4):251-65. PubMed ID: 2260923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model.
    Chambers TJ; Liang Y; Droll DA; Schlesinger JJ; Davidson AD; Wright PJ; Jiang X
    J Virol; 2003 Mar; 77(6):3655-68. PubMed ID: 12610141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis.
    Pincus S; Mason PW; Konishi E; Fonseca BA; Shope RE; Rice CM; Paoletti E
    Virology; 1992 Mar; 187(1):290-7. PubMed ID: 1736531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice.
    Fonseca BA; Pincus S; Shope RE; Paoletti E; Mason PW
    Vaccine; 1994; 12(3):279-85. PubMed ID: 8165861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation and immunogenicity of recombinant yellow fever 17D-dengue type 2 virus for rhesus monkeys.
    Galler R; Marchevsky RS; Caride E; Almeida LF; Yamamura AM; Jabor AV; Motta MC; Bonaldo MC; Coutinho ES; Freire MS
    Braz J Med Biol Res; 2005 Dec; 38(12):1835-46. PubMed ID: 16302098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.
    Brandriss MW; Schlesinger JJ; Walsh EE; Briselli M
    J Gen Virol; 1986 Feb; 67 ( Pt 2)():229-34. PubMed ID: 3944585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection.
    Mason PW; Pincus S; Fournier MJ; Mason TL; Shope RE; Paoletti E
    Virology; 1991 Jan; 180(1):294-305. PubMed ID: 1845826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus.
    Yasuda A; Kimura-Kuroda J; Ogimoto M; Miyamoto M; Sata T; Sato T; Takamura C; Kurata T; Kojima A; Yasui K
    J Virol; 1990 Jun; 64(6):2788-95. PubMed ID: 2159544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 viruses.
    Caufour PS; Motta MC; Yamamura AM; Vazquez S; Ferreira II; Jabor AV; Bonaldo MC; Freire MS; Galler R
    Virus Res; 2001 Nov; 79(1-2):1-14. PubMed ID: 11551641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dengue 2 virus envelope protein expressed by a recombinant vaccinia virus fails to protect monkeys against dengue.
    Deubel V; Kinney RM; Esposito JJ; Cropp CB; Vorndam AV; Monath TP; Trent DW
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1921-9. PubMed ID: 3404119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue virus premembrane and membrane proteins elicit a protective immune response.
    Bray M; Lai CJ
    Virology; 1991 Nov; 185(1):505-8. PubMed ID: 1926792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus encephalitis.
    Bray M; Zhao BT; Markoff L; Eckels KH; Chanock RM; Lai CJ
    J Virol; 1989 Jun; 63(6):2853-6. PubMed ID: 2724416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice.
    Men RH; Bray M; Lai CJ
    J Virol; 1991 Mar; 65(3):1400-7. PubMed ID: 1995950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential dengue cross-reactive and neutralizing antibody responses in BALB/c and Swiss albino mice induced by immunization with flaviviral vaccines and by infection with homotypic dengue-2 virus strains.
    Lim CS; Chua JJ; Wilkerson J; Chow VT
    Viral Immunol; 2006; 19(1):33-41. PubMed ID: 16553548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of dengue virus structural proteins and nonstructural protein NS1 by a recombinant vaccinia virus.
    Zhao BT; Prince G; Horswood R; Eckels K; Summers P; Chanock R; Lai CJ
    J Virol; 1987 Dec; 61(12):4019-22. PubMed ID: 3316711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response.
    van Der Most RG; Murali-Krishna K; Ahmed R; Strauss JH
    J Virol; 2000 Sep; 74(17):8094-101. PubMed ID: 10933719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.
    Guirakhoo F; Zhang Z; Myers G; Johnson BW; Pugachev K; Nichols R; Brown N; Levenbook I; Draper K; Cyrek S; Lang J; Fournier C; Barrere B; Delagrave S; Monath TP
    J Virol; 2004 Sep; 78(18):9998-10008. PubMed ID: 15331733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus.
    Chang GJ; Hunt AR; Holmes DA; Springfield T; Chiueh TS; Roehrig JT; Gubler DJ
    Virology; 2003 Feb; 306(1):170-80. PubMed ID: 12620809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.